用线粒体DNA突变诱导的药物释放系统进行基因型特异精确瘤治疗
Yanan Li1,2, Ru Xu1,2, Yonghua Wu1,2
1School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
Science advances
|September 27, 2023
概括
这项研究引入了一种新的突变诱导药物释放系统 (MIDRS),通过利用线粒体DNA (mtDNA) 突变,精确地准瘤细胞. 这种创新方法使得基因型特异性癌症治疗具有显著的抗瘤效果,并减少对正常细胞的影响.
科学领域:
- 生物医学工程 生物医学工程
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 在癌症治疗中,在保护健康组织的同时准瘤细胞仍然是一个重大挑战.
- 线粒体DNA (mtDNA) 突变在癌症中普遍存在,并影响新陈代谢平衡,呈现出潜在的治疗标.
- 开发针对特定遗传标记的精确药物输送系统对于个性化医疗至关重要.
研究的目的:
- 设计和评估一种突变诱导的药物释放系统 (MIDRS),用于精确杀死瘤细胞.
- 利用Cas12a在mtDNA中识别单核酸变异 (SNV) 的能力,以实现向药物输送.
- 调查MIDRS在触发先天性和适应性免疫反应的潜力,以加强癌症治疗.
主要方法:
- 基于Cas12a的SNV识别和跨裂变活动的突变诱导药物释放系统 (MIDRS) 的开发.
- 利用Ce6作为器官级光动力学治疗的模型药物.
- 在单边,双边和异质瘤模型中的体内评估,以评估抗瘤疗效和特异性.
主要成果:
- MIDRS成功识别了具有特定mtDNASNVs的瘤组织,从而实现了精确的细胞内药物释放.
- 通过MIDRS进行的器官级光动力学治疗显示出显著的抗瘤效果 (~82.6%),而不会损害正常细胞.
- 该系统有效地触发了先天性和适应性全身抗瘤免疫反应.
- 在基因型特异性释放化疗药物方面,MIDRS显示出了多功能性.
结论:
- 通过准特定mtDNA突变,MIDRS提供了一种精确有效的瘤细胞杀死策略.
- 该系统有望实现个性化癌症治疗,通过实现基因型特异性药物输送和增强抗瘤免疫力.
- 这种方法在开发突变特异性,针对癌症的个性化治疗策略方面取得了重大进展.
更多相关视频
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.3K
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
1.8K
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K